Skip to main content
Journal of General Internal Medicine logoLink to Journal of General Internal Medicine
. 2019 Jun 21;35(1):43–50. doi: 10.1007/s11606-019-05111-6

Provider-Patient Discussions About Smoking and the Impact of Lung Cancer Screening Guidelines: NHIS 2011–2015

Jinhai Huo 1,, Tong Han Chung 2, Bumyang Kim 3, Ashish A Deshmukh 1, Ramzi G Salloum 4, Jiang Bian 4
PMCID: PMC6957585  PMID: 31228049

Abstract

Background

Clinical practice guidelines for treating tobacco use and lung cancer screening guidelines recommend smoking cessation counseling to current smokers by health care professionals.

Objective

Our objective was to determine the contemporary patterns of current smokers’ discussions about smoking with their health care professionals in the USA.

Design, Setting, and Participants

We conducted an observational study of 30,132 current smokers (weighted sample 40,126,006) for the years 2011 to 2015 using data from the National Health Interview Survey.

Main Measures

Our main outcome was the proportion of current smokers who had discussions about smoking with their health care professionals. We used the Cochran-Armitage trend test to evaluate the temporal trends in current smokers’ discussions about smoking, and used a multivariable logistic model to determine the predictors of discussions about smoking, controlling for smokers’ demographics, health status, and receipts of lung cancer screening.

Key Results

Our study found the proportion of current smokers who had discussions about smoking with their health care professionals increased from 51.3% in 2011 to 55.4% in 2015 (P-trend < 0.0001). However, about 15% of current smokers who underwent lung cancer screening did not have or could not recall discussions about smoking with their health care professionals. In multivariable analyses and sensitivity analysis, the predictors of discussions about smoking were being a heavy smoker, receipt of lung cancer screening, being non-Hispanic white, having a physician office visit in the past year, being diagnosed with respiratory conditions, having fair or poor health, and having insurance coverage.

Conclusions

The results demonstrated a steady but slow increase in current smokers’ discussions about smoking with their health care professionals in recent years, especially among heavy smokers. More than 40% of current smokers did not have or could not recall any discussions about smoking with their health care professionals.

KEY WORDS: current smoker, communication, smoking, lung cancer screening

INTRODUCTION

Since the first Surgeon General’s Report on Smoking and Health in 1964,1 the prevalence of smoking has dropped from a projected 51.1 to 15.1% in 2015.2, 3 However, smoking remains the leading preventable cause of mortality in the USA4 and causes a substantial economic burden to society.4, 5 In recent years, many changes in healthcare policy, clinical practice guidelines, and intensive media campaigns have promoted discussions about smoking with health care professionals. Such initiatives include the updated 2010 Centers for Medicare and Medicaid Services (CMS) memo on counseling to prevent tobacco use, which extended insurance coverage of smoking cessation counseling to asymptomatic Medicare beneficiaries6 and the 2011 Patient Protection and Affordable Care Act which required full coverage for smoking cessation services.7 The 2011–2016 “meaningful use of certified electronic health records” policy required health care providers to document smoking status for more than 50% of patients aged 13 years or older in phase I and 80% in phase II.8 Also, there were substantial media campaigns related to smoking around the 50th anniversary of the 1964 release of the first Surgeon General’s Report.1, 4 Furthermore in 2015, CMS issued a decision memo on promoting the promising lung cancer screening (LCS) using low-dose computed tomography scans, which required shared decision-making between physicians and patients, including a discussion on the importance of smoking cessation.9

The impact of these policy changes and media campaigns on discussions about smoking among the general population and vulnerable sub-populations remains uncertain, however. It is important to understand the changes in the patterns of patient-provider discussions about smoking among specific subgroups of current smokers who have a high prevalence of smoking but who are less likely to quit, for instance, those with low socioeconomic status, those with no insurance, and minorities.1013 Even for current smokers who had discussions about smoking with their physicians, they may not be able to recall their conversations, particularly if discussions about smoking were very brief with insufficient intensity.14, 15 Findings from previous studies have shown significant variation in the rates of patient-provider discussions about smoking among adults across different settings.1618 A study in Minnesota reported that 51.3% current smokers had been asked about tobacco use or advised to quit,19 a rate similar to the that reported in a study using the 2010 National Health Interview Survey data.20 Another study used National Adult Tobacco Survey found that the 65.8% current cigarette smokers were advised to quit.21 The reported prevalence of smoking cessation counseling was high in nine nonprofit HMOs participating National Cancer Institute-funded Cancer Research Network, 90% of smokers were asked about smoking, 71% were advised to quit.16

This study was designed to provide a population-based estimate of the prevalence of patient-provider discussions about smoking among current smokers using contemporary national survey data. Furthermore, we determined whether the rates of discussions about smoking differed by patient demographic factors, especially among minority groups and the uninsured population. The CMS decision memo on promoting the LCS and the US Preventive Services Task Force (USPSTF)’s grade B recommendation on the LCS may have affected the rate of smoking cessation counseling. Therefore, we also sought to determine whether the CMS and USPSTF endorsing LCS were associated with any trends in rates of physician-patient discussions about smoking.

METHODS

Data

We analyzed data from the 2011 to 2015 National Health Interview Survey (NHIS). Initiated in 1957 by the Centers for Disease Control and Prevention, the NHIS is one of the largest in-person household health survey databases of non-institutionalized civilians in the USA. The survey is administered by the US Census Bureau with an oversampling of minority groups, including Hispanics, African Americans, and Asian Americans for better representativeness of the survey population. The NHIS collects information each year on various health-related topics and provides data for the purpose of monitoring healthcare trends and conducting research to determine contemporary health issues and to improve access to appropriate health care.

Study Population

We limited our analytic sample to respondents who were aged 18 years and older and were current smokers, because questions on discussions about smoking were only applicable to this subset of respondents. We excluded respondents who did not answer the question on the discussions about smoking with health care professionals (N = 23, 0.07% of study sample) since we were not sure whether these respondents had a discussion on smoking or not. We also excluded individuals with responses of “refused” (N = 517, 1.68%) and “not ascertained” (N = 22, 0.07%) to this question because for these respondents the survey process was likely discontinued prior to these questions ever being asked.

Predictors and Outcomes of Interest

The outcome of interest was whether current smokers and their physicians or other health care professionals discussed smoking with them in the past 12 months at the time of survey: “During the past 12 months, has a doctor or other health professional talked to you about your smoking?” To explore predictors associated with discussions about smoking, we obtained and constructed the following variables from the NHIS data: age, sex, race/ethnicity, employment status, insurance, education level, secondhand smoke exposure, personal history of cancer, respiratory conditions, having activity limitations due to lung/breathing problems, health status, access to healthcare resources, and number of office visits to doctors or other health professionals in the past year. Because the recent CMS coverage for LCS requires physicians to offer smoking cessation consultation to LCS-eligible smokers, we also stratified current smokers based on their eligibility for LCS to determine the impact of the recent LCS policy: LCS eligibility criteria included an age range of 55–77 years and at least a 30-pack-year smoking history; all others were considered ineligible.

Statistical Analysis

We assessed whether the demographic and health characteristics of respondents differed by the receipt of discussions about smoking using the Pearson chi-square test. We used the Cochran-Armitage trend test to evaluate the temporal trends in discussions about smoking over the study period. To examine the factors associated with discussions about smoking among current smokers, we created a multivariable logistic model controlled for statistically significant or clinically meaningful characteristics using the SURVEYLOGISTIC procedure. We further stratified respondents by insurance status, age, and race/ethnicity. Within each subgroup, we compared the receipt of discussions about smoking using the SURVEYFREQ procedure with a Rao-Scott chi-square test. We used NHIS analytic weights to account for the multistage sample design. Statistical significance was defined as a P value less than 0.01. Statistical analysis was conducted with SAS version 9.4 (Cary, NC). This study was considered exempt from the Institutional Review Board at the University of Florida.

RESULTS

The analytic sample consisted of 30,132 current smokers (weighted sample size 40,126,006). Table 1 provides the baseline characteristics and demographics of current smokers from 2011 to 2015, stratified by whether they discussed smoking with a health care professional. As shown in Table 1, most current smokers who had discussed about smoking with a health care professional were aged 55 years or older (55 to 64 years old, 63.9%; 65 to 74 years old, 67.4%; and 75+ years, 64.5%), female (59.2%), non-Hispanic white (54.7%), had higher education (bachelor’s degree or higher 54.6%), were covered by public insurance (65.4%), had access to a usual source of health care other than the emergency room (62.0%), visited a physician’s office more often (1 visit, 49.6%; 2 to 5 visits, 68.2%; 6+ visits, 76.2%), and were diagnosed with respiratory diseases (all p < 0.001).

Table 1.

Demographics and Clinical Characteristics of Adults Who Had a Discussion with a Health Care Professional About Smoking: National Health Interview Survey 2010–2015

Receipt of discussion about smoking
Yes No
Characteristics Total no. Weighted frequency No. % No. % P value
Overall 30,132 40,126,006 15,970 53.0 14,162 47.0
Age, years < .0001
  18–39 11,896 17,286,062 5123 43.0 6773 57.0
  40–54 9176 12,688,393 4969 54.6 4207 45.4
  55–64 5491 6,559,683 3503 63.9 1988 36.1
  65–74 2684 2,724,692 1808 67.4 876 32.6
  75+ 885 867,175 567 64.5 318 35.5
Sex < .0001
  Male 15,506 21,895,431 7280 46.3 8226 53.7
  Female 14,626 18,230,575 8690 59.2 5936 40.8
Race/ethnicity < .0001
  NH White 20,008 29,328,804 11,022 54.7 8986 45.3
  NH Black 4921 5,009,075 2796 51.8 2125 48.2
  Hispanic 3645 4,093,862 1443 37.3 2202 62.7
  NH Other 1558 1,694,265 709 44.8 849 55.2
Currently employed < .0001
  No 13,027 16,401,781 7868 58.9 5159 41.1
  Yes 17,105 23,724,225 8102 47.5 9003 52.5
Education 0.0003
  Less than high-school graduate 6121 7,781,979 3149 49.6 2972 50.4
  High-school graduate/GED 10,391 14,449,854 5358 51.0 5033 49.0
  Some college/associate degree 9909 13,010,939 5423 54.1 4486 45.9
  Bachelor’s degree or more 3711 4,883,234 2040 54.6 1671 45.4
NLST < .0001
  Low 14,129 17,809,998 8240 57.9 5889 42.1
  High 3444 4,187,043 2368 69.5 1076 30.5
  Unknown 12,559 18,128,965 5362 42.6 7197 57.4
Attempted to quit smoking in the last 12 months (current smokers) < .0001
  No 15,766 21,113,412 7701 48.0 8065 52.0
  Yes 14,346 18,989,630 8258 56.9 6088 43.1
Personal history of cancer other than lung < .0001
  No 27,994 37,502,079 14,459 51.0 13,535 49.0
  Yes 2138 2,623,927 1511 68.4 627 31.6
Respiratory conditions diagnosed by a health professional < .0001
  None 23,776 32,020,873 11,695 48.7 12,081 51.3
  Any 6356 8,105,134 4275 65.9 2081 34.1
Emphysema (ever) < .0001
  No 28,773 38,537,035 14,861 51.0 13,912 49.0
  Yes 1359 1,588,972 1109 80.9 250 19.1
Asthma (ever) < .0001
  No 25,605 34,324,387 13,085 50.6 12,520 49.4
  Yes 4527 5,801,620 2885 61.8 1642 38.2
Asthma (attack in past 12 months) < .0001
  No 28,646 38,291,440 14,899 51.3 13,747 48.7
  Yes 1486 1,834,567 1071 70.4 415 29.6
Chronic bronchitis (past 12 months) < .0001
  No 27,816 37,304,742 14,163 50.2 13,653 49.8
  Yes 2316 2,821,265 1807 78.0 509 22.0
Activity limitations due to lung/breathing problem < .0001
  No 28,824 38,587,353 14,898 51.0 13,926 49.0
  Yes 1308 1,538,653 1072 80.9 236 19.1
General health status < .0001
  Excellent/very good/good 23,251 32,030,635 11,256 48.0 11,995 52.0
  Fair/poor 6881 8,095,371 4714 68.6 2167 31.4
Insurance status < .0001
  Uninsured 7626 10,126,837 2458 31.9 5168 68.1
  Public only 9170 10,413,736 6099 65.4 3071 34.6
  Private 13,167 19,277,044 7326 55.7 5841 44.3
Usual source of health care other than ER < .0001
  No 7434 10,203,591 1751 23.3 5683 76.7
  Yes 22,698 29,922,415 14,219 62.0 8479 38.0
Number of office visits to doctor or other health professional in last year < .0001
  0 7805 10,780,717 1057 13.1 6748 86.9
  1 4795 6,511,212 2403 49.6 2392 50.4
  2–5 10,308 13,756,176 6993 68.2 3315 31.8
  6+ 7224 9,077,900 5517 76.2 1707 23.8

LCS lung cancer screening, NH non-Hispanic, GED general education development

The frequency of discussions about smoking among current smokers increased slightly from 51.3% in 2011 to 55.4% in 2015 (P-trend < 0.0001) (Fig. 1). However, the growth rate was low for the first 4 years from 51.3% in 2011 to 52.4% in 2014 but rose significantly in 2015. When this trend was stratified by eligibility for LCS, we found that the proportion of current smokers who had discussions about smoking with health care professionals was greater among LCS-eligible individuals compared with those not eligible, 69.5% vs. 57.9% (Fig. 2). The significant increase in the proportion of discussions about smoking was observed in younger smokers aged 18–39 who were LCS non-eligible, from 41.2 to 45.3% (Fig. 2).

Figure 1.

Figure 1

Trends in the proportion of smokers who had discussions with their health care professional about smoking between 2011 and 2015: National Health Interview Survey.

Figure 2.

Figure 2

Trends in the proportion of smokers who had discussions with their health care professional about smoking, stratified by eligibility for lung cancer screening between 2011 and 2015: National Health Interview Survey.

In the analysis using smokers who underwent LCS using either CT scans or chest X-rays (only 2015 NHIS provided information on receipt of LCS), the rates of discussions about smoking were 84.0% for those who received CT scans and 86.0% for those who received chest X-rays. In the subgroup analysis, the study sample was stratified by age group and insurance status. Among those who were 65 years or younger, the rate of discussions about smoking was lowest among those with no insurance coverage (32.0%); the rates were higher (54.4%) among those with private insurance, and highest among those with public insurance coverage (66.2%). For smokers older than 65, the rates of discussion about smoking were similar between samples with public insurance coverage (67.4%) and those with both public insurance and private complementary insurance coverage (66.7%) (Fig. 3).

Figure 3.

Figure 3

The proportion of smokers who had discussions with their health care professional about smoking, stratified by age group and insurance status: National Health Interview Survey 2011–2015.

In the multivariable analysis, those surveyed in 2015 were more likely to have discussed smoking with their health care professionals (odds ratio [OR] 1.16, 95% confidence interval [CI] 1.04–1.30 for 2015 vs. the referent group in 2011). Those in the analytic sample who met the LCS eligibility criteria also had higher odds of having had a discussion about smoking (OR 1.53; 95% CI 1.32–1.77; P < .001) (Table 2). The other factors associated with discussions about smoking were younger age, being non-Hispanic white, having a quit attempt in the past year, a diagnosis of a respiratory condition, having chronic bronchitis, having an activity limitation due to lung/breath problem, reporting fair or poor health, having public or private insurance coverage, having a usual source of health care other than the emergency room, and having visited a doctor or other health care professional more often in the past year.

Table 2.

Weighted Logistic Regression Analysis Examining Patient-Provider Discussions About Smoking

Receipt of discussion about smoking
Characteristics OR 95% CI P value
Year of survey
  2011 1.00
  2012 1.00 0.90 1.11 0.957
  2013 1.06 0.95 1.18 0.337
  2014 1.06 0.94 1.20 0.345
  2015 1.16 1.04 1.30 0.009
LCS eligibility
Non-eligible (low-risk smoke) 1.00
  Eligible 1.53 1.32 1.77 < .001
  Unknown 0.30 0.24 0.38 < .001
Age, years
  18–39 1.00
  40–54 0.42 0.32 0.54 < .001
  55–64 0.42 0.32 0.54 < .001
  65–74 0.38 0.29 0.50 < .001
  75+ 0.34 0.25 0.46 < .001
Sex
  Male 1.00
  Female 1.07 0.99 1.14 0.087
Race/ethnicity
  White 1.00
  Black 0.96 0.86 1.06 0.404
  Hispanic 0.68 0.61 0.76 < .001
  Other 0.83 0.69 1.00 0.046
Currently employed
  No 1.00
  Yes 1.00 0.92 1.10 0.928
Education
  Less than high-school graduate 1.00
  High-school graduate/GED 1.01 0.91 1.12 0.915
  Some college/associate degree 0.99 0.88 1.12 0.883
  Bachelor’s degree or more 0.91 0.79 1.04 0.158
Attempted to quit smoking in the last 12 months (current smokers)
  No 1.00
  Yes 1.45 1.34 1.57 < .001
Personal history of cancer other than lung
  No 1.00
  Yes 1.06 0.91 1.25 0.454
Respiratory conditions diagnosed by a health professional
  None 1.00
  Any 1.34 1.00 1.79 0.049
Emphysema (ever)
  No 1.00
  Yes 1.24 0.91 1.68 0.174
Asthma (ever)
  No 1.00
  Yes 0.84 0.64 1.11 0.219
Asthma (attack in past 12 months)
  No 1.00
  Yes 1.08 0.86 1.35 0.512
Chronic bronchitis (past 12 months)
  No 1.00
  Yes 1.52 1.20 1.93 < .001
Activity limitations due to lung/breathing problem
  No 1.00
  Yes 1.70 1.34 2.15 < .001
General health status
  Excellent/very good/good 1.00
  Fair/poor 1.27 1.15 1.41 < .001
Insurance status
  Uninsured 1.00
  Public only 1.41 1.25 1.59 < .001
  Private 1.23 1.11 1.35 < .001
Usual source of health care other than ER
  No 1.00
  Yes 1.90 1.73 2.09 < .001
Number of office visits to doctor or other health professional in last year
  0 1.00
  1 5.35 4.69 6.09 < .001
  2–5 9.60 8.43 10.93 < .001
  6+ 11.72 10.21 13.44 < .001

LCS lung cancer screening, NH non-Hispanic, GED general education development

DISCUSSION

In a nationally representative sample of adult smokers, we found that the prevalence of discussions about smoking with health care professionals experienced a low growth rate from 51.3% in 2011 to 52.4% in 2014, but at a higher growth rate from 52.4% in 2014 to 55.4% in 2015 Additionally, current smokers who received LCS via either CT scans or chest X-rays had the highest rate of discussions about smoking than all other smokers. Among racial/ethnic groups, the prevalence of discussions about smoking was significantly lower among Hispanics than among smokers in other racial/ethnic groups. It is worth to note that the prevalence rates between non-Hispanic white and non-Hispanic black smokers were comparable.

Our finding of 15% of current smokers who underwent LCS did not have a discussion about smoking with their health care professionals raises the possibility that these smokers actually had a conversation on smoking with their physicians who prescribed LCS but cannot recall it ever happened. Since smoking is the top factor contributing to 80 to 90% of lung cancer cases, therefore, both CMS and the USPSTF required that not only a brief recoding of smoking status but also a smoking cessation counseling and intervention should be integrated into the LCS program before smokers undergo LCS.9 The clinical guidelines and reimbursement policies for LCS consistently stated that smoking cessation cannot be replaced by low-dose CT scans and that smoking cessation should still be the priority for all current smokers.9, 2224 Even though the 2011 National Lung Screening Trial results showed that lung cancer screening using low-dose CT scans could reduce cancer mortality by 20% compared with ineffective chest X-rays,25 smoking cessation is still more effective and cost-effective than LCS in reducing lung cancer mortality. As shown in our study that many LCS recipient could not recall the discussion about smoking, there is a clear need for effective ways to deliver smoking cessation services along with LCS.26, 27

Our study adds valuable information on further understanding racial disparities involved in the prevalence of discussions about smoking with health care professionals. As indicated in our study, the gap between non-Hispanic whites and non-Hispanic blacks has been diminishing, while the gap between non-Hispanics and Hispanics persisted. In many previous studies that utilized national survey data, the gap found between non-Hispanics and Hispanic groups was mostly larger than that between non-Hispanic whites and non-Hispanic blacks.28, 29 English language proficiency was once considered a major barrier for Hispanics to discuss their smoking behavior. The values and beliefs of the culture, as well as social norms, may have also led to a lower rate of discussions about smoking among the Hispanic population. However, there is no doubt that having a discussion about smoking with health care professionals is the first step to increasing current smokers’ motivation to quit and also increasing the odds of successful cessation3033; therefore, to control the smoking-related burden among the Hispanic population, more efforts are needed to promote discussions about smoking in this ethnic group.

We noted a significantly improved rate for discussions about smoking among respondents with insurance coverage. Curry et al. have reported variations in the use of smoking cessation services across four different types of health insurance and found that the use of smoking cessation services was highest among current smokers with full insurance coverage.34 The recent Medicaid healthcare expansion program under the Affordable Care Act offers insurance coverage for many previously uninsured smokers and is expected to increase the use of smoking cessation services in this population.3537 This expanded insurance coverage may also increase the number of physician office visits. As shown in our study, the number of physician office visits is another factor associated with higher odds of physician-patient discussion about smoking.

Our study is subject to limitations. The NHIS question on the presence of discussions about smoking with health care professionals was vague, and this discussion might have been very brief. An effective discussion on smoking involves various components that were not captured in the survey. In addition, the NHIS is a cross-sectional survey that does not follow up with the respondents after the initial survey. The effect of discussions about smoking thus is unknown, and the impact of increased prevalence of discussions about smoking on the rate of smoking cessation in the general population is uncertain.38 Additionally, the cross-sectional data also limit the capability to conclude causal relationships between receipt of LCS and discussions about smoking. The survey on smoker self-reported discussions could be biased due to recall problems, and this issue may be addressed in the future using other data sources such as the electronic health record data. For non-native English speakers, language can also be a barrier to effective discussions on smoking and therefore respondents may be less likely to correctly recall the intent of the conversation. This issue may be more severe for Hispanics. Moreover, some smokers may have quit smoking after the discussion on smoking with health care professionals in the past 12 months. The NHIS survey did not ask this question to the smokers who recently quit smoking and it is likely that effective counseling by their doctor or health professional may have depressed the actual percentage of smokers who discussed smoking during the past 12 months.

In conclusion, using a nationally representative population, our study determined the prevalence of discussions about smoking among current smokers over 5 years. We found a steady increase and a significant rise in these discussions among smokers in recent years, and especially among smokers who underwent LCS. However, more than 40% of current smokers did not have discussions about smoking with their health care professionals or cannot recall they ever had this discussion. Importantly, our study demonstrated significant ethnic disparities in discussions about smoking with health care professionals. However, the barriers to minority smokers engaging in smoking-related discussions is still unknown. Herein, to maximize the benefits of these recent policy changes and media campaigns on smoking cessation and to reduce smoking-related societal and economic burden, more health promotion programs are needed to engage current smokers from vulnerable populations in discussions about smoking with their health care professionals. Future policy efforts should also address these persistent gaps.

Funders

The study was supported by the University of Florida Health Cancer Center Research Pilot Grant through the Florida Consortium of National Cancer Institute Centers Program at the University of Florida (Dr. Huo and Dr. Bian).

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they do not have a conflict of interest.

Disclaimer

The content is solely the responsibility of the authors and does not necessarily represent the official views of the UF Health Cancer Center.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Smoking and health: report of the advisory committee to the Surgeon General of the Public Health Service (Report No. 1103). Washington DC: U.S. Department of Health, Education, and Welfare, Public Health Service, CDC; 1964.
  • 2.Centers for Disease Control and Prevention (CDC) Current Cigarette Smoking Among Adults in the United States. Atlanta: Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion; 2015. [Google Scholar]
  • 3.Holford TR, Meza R, Warner KE, Meernik C, Jeon J, Moolgavkar SH, et al. Tobacco control and the reduction in smoking-related premature deaths in the United States, 1964-2012. JAMA. 2014;311(2):164–71. doi: 10.1001/jama.2013.285112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.U.S. Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
  • 5.Xu X, Bishop EE, Kennedy SM, Simpson SA, Pechacek TF. Annual healthcare spending attributable to cigarette smoking: an update. Am J Prev Med. 2015;48(3):326–33. doi: 10.1016/j.amepre.2014.10.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Centers for Medicare & Medicaid Services. National Coverage Determination (NCD) for Counseling to Prevent Tobacco Use (210.4.1). 2010. [PubMed]
  • 7.Final Update Summary. Tobacco Smoking Cessation in Adults, Including Pregnant Women: Behavioral and Pharmacotherapy Interventions. U.S. Preventive Services Task Force; 2015. https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions. Accessed Feb 22 2019. [DOI] [PubMed]
  • 8.Health information technology (Health IT). EHR incentives and certification. 2013. https://www.healthit.gov/providers-professionals/how-attain-meaningful-use. Accessed Feb 22 2019.
  • 9.Decision Memo for Screening for Lung Cancer with Low Dose Computed Tomography (LDCT) (CAG-00439N). Baltimore, MD: The Centers for Medicare & Medicaid Services; 2015.
  • 10.Barbeau EM, Krieger N, Soobader MJ. Working class matters: socioeconomic disadvantage, race/ethnicity, gender, and smoking in NHIS 2000. Am J Public Health. 2004;94(2):269–78. doi: 10.2105/ajph.94.2.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Laveist TA, Thorpe RJ, Jr, Mance GA, Jackson J. Overcoming confounding of race with socio-economic status and segregation to explore race disparities in smoking. Addiction. 2007;102(Suppl 2):65–70. doi: 10.1111/j.1360-0443.2007.01956.x. [DOI] [PubMed] [Google Scholar]
  • 12.Novotny TE, Warner KE, Kendrick JS, Remington PL. Smoking by blacks and whites: socioeconomic and demographic differences. Am J Public Health. 1988;78(9):1187–9. doi: 10.2105/ajph.78.9.1187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Lantz PM, House JS, Lepkowski JM, Williams DR, Mero RP, Chen J. Socioeconomic factors, health behaviors, and mortality: results from a nationally representative prospective study of US adults. JAMA. 1998;279(21):1703–8. doi: 10.1001/jama.279.21.1703. [DOI] [PubMed] [Google Scholar]
  • 14.Folsom AR, Grimm RH., Jr Stop smoking advice by physicians: a feasible approach? Am J Public Health. 1987;77(7):849–50. doi: 10.2105/AJPH.77.7.849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Szatkowski L, McNeill A, Lewis S, Coleman T. A comparison of patient recall of smoking cessation advice with advice recorded in electronic medical records. BMC Public Health. 2011;11(1):291. doi: 10.1186/1471-2458-11-291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Quinn VP, Stevens VJ, Hollis JF, Rigotti NA, Solberg LI, Gordon N, et al. Tobacco-cessation services and patient satisfaction in nine nonprofit HMOs. Am J Prev Med. 2005;29(2):77–84. doi: 10.1016/j.amepre.2005.04.006. [DOI] [PubMed] [Google Scholar]
  • 17.Conroy MB, Majchrzak NE, Regan S, Silverman CB, Schneider LI, Rigotti NA. The association between patient-reported receipt of tobacco intervention at a primary care visit and smokers’ satisfaction with their health care. Nicotine Tob Res. 2005;7(Suppl 1):S29–34. doi: 10.1080/14622200500078063. [DOI] [PubMed] [Google Scholar]
  • 18.Thorndike AN, Regan S, Rigotti NA. The treatment of smoking by US physicians during ambulatory visits: 1994 2003. Am J Public Health. 2007;97(10):1878–83. doi: 10.2105/AJPH.2006.092577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Solberg LI, Boyle RG, Davidson G, Magnan SJ, Carlson CL, eds. Patient satisfaction and discussion of smoking cessation during clinical visits. Mayo Clinic Proceedings. Elsevier; 2001. [DOI] [PubMed]
  • 20.Kruger J, Shaw L, Kahende J, Frank E. Health care providers’ advice to quit smoking, National Health Interview Survey, 2000, 2005, and 2010. Prev Chronic Dis. 2012;9:E130-E. doi: 10.5888/pcd9.110340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.King BA, Dube SR, Babb SD, McAfee TA. Patient-reported recall of smoking cessation interventions from a health professional. Prev Med. 2013;57(5):715–7. doi: 10.1016/j.ypmed.2013.07.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Wender R, Fontham ET, Barrera E, Jr, Colditz GA, Church TR, Ettinger DS, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin. 2013;63(2):107–17. doi: 10.3322/caac.21172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Lung Cancer. Screening. U.S. Preventive Services Task Force; 2013. https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/lung-cancer-screening. Accessed Feb 22 2019.
  • 24.Tanner NT, Kanodra NM, Gebregziabher M, Payne E, Halbert CH, Warren GW, et al. The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial. Am J Respir Crit Care Med. 2016;193(5):534–41. doi: 10.1164/rccm.201507-1420OC. [DOI] [PubMed] [Google Scholar]
  • 25.National Lung Screening Trial Research T. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409. doi: 10.1056/NEJMoa1102873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Park ER, Gareen IF, Japuntich S, Lennes I, Hyland K, DeMello S, et al. Primary Care Provider-Delivered Smoking Cessation Interventions and Smoking Cessation Among Participants in the National Lung Screening Trial. JAMA Intern Med. 2015;175(9):1509–16. doi: 10.1001/jamainternmed.2015.2391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Pedersen JH, Tonnesen P, Ashraf H. Smoking cessation and lung cancer screening. Ann Transl Med. 2016;4(8):157. doi: 10.21037/atm.2016.03.54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Agency for Healthcare Research and Quality. National Healthcare Quality & Disparities Reports. Rockville, MD; 2013. https://www.ahrq.gov/research/findings/nhqrdr/index.html. Accessed 22 Feb 2019.
  • 29.Houston TK, Scarinci IC, Person SD, Greene PG. Patient smoking cessation advice by health care providers: the role of ethnicity, socioeconomic status, and health. Am J Public Health. 2005;95(6):1056–61. doi: 10.2105/AJPH.2004.039909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Fiore M. Treating tobacco use and dependence: 2008 update: Clinical practice guideline. Diane Publishing; 2008.
  • 31.Wu D, Ma GX, Zhou K, Zhou D, Liu A, Poon AN. The effect of a culturally tailored smoking cessation for Chinese American smokers. Nicotine Tob Res. 2009;11(12):1448–57. doi: 10.1093/ntr/ntp159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2013(5):CD000165. 10.1002/14651858.CD000165.pub4. [DOI] [PMC free article] [PubMed]
  • 33.Kotz D, Brown J, West R. ‘Real-world’ effectiveness of smoking cessation treatments: a population study. Addiction. 2014;109(3):491–9. doi: 10.1111/add.12429. [DOI] [PubMed] [Google Scholar]
  • 34.Curry SJ, Grothaus LC, McAfee T, Pabiniak C. Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization. N Engl J Med. 1998;339(10):673–9. doi: 10.1056/NEJM199809033391006. [DOI] [PubMed] [Google Scholar]
  • 35.Bailey SR, Hoopes MJ, Marino M, Heintzman J, O'Malley JP, Hatch B, et al. Effect of Gaining Insurance Coverage on Smoking Cessation in Community Health Centers: A Cohort Study. J Gen Intern Med. 2016;31(10):1198–205. doi: 10.1007/s11606-016-3781-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Land T, Warner D, Paskowsky M, Cammaerts A, Wetherell L, Kaufmann R, et al. Medicaid coverage for tobacco dependence treatments in Massachusetts and associated decreases in smoking prevalence. PLoS One. 2010;5(3):e9770. doi: 10.1371/journal.pone.0009770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Greene J, Sacks RM, McMenamin SB. The impact of tobacco dependence treatment coverage and copayments in Medicaid. Am J Prev Med. 2014;46(4):331–6. doi: 10.1016/j.amepre.2013.11.019. [DOI] [PubMed] [Google Scholar]
  • 38.Boyle R, Solberg L, Fiore M. Use of electronic health records to support smoking cessation. Cochrane Database Syst Rev. 2014(12). 10.1002/14651858.CD008743.pub3. [DOI] [PMC free article] [PubMed]

Articles from Journal of General Internal Medicine are provided here courtesy of Society of General Internal Medicine

RESOURCES